QIMR Berghofer

Genetic and environmental risk factors in the non-medical use of over-the-counter or prescribed analgesics, and their relationship to major classes of licit and illicit substance use and misuse in a population-based sample of young adult twins.

Abstract

BACKGROUND AND AIMS: The non-medical use of over-the-counter or prescribed analgesics (NMUA) is a significant public health problem. Little is known about the genetic and environmental etiology of NMUA and how these risks relate to other classes of substance use and misuse. Our aims were to estimate the heritability NMUA and sources of genetic and environmental covariance with cannabis and nicotine use, cannabis and alcohol use disorders and nicotine dependence in Australian twins. DESIGN: Biometrical genetic analyses or twin methods using structural equation univariate and multivariate modeling. SETTING: Australia. PARTICIPANTS: =25.9, SD=3.6, range=18-38) from the Brisbane Longitudinal Twin Study retrospectively assessed between 2009 and 2016. MEASUREMENTS: Self-reported NMUA (non-opioid or opioid-based), lifetime nicotine, cannabis and opioid use, DSM-V cannabis and alcohol use disorders and the Fagerström Test for Nicotine Dependence. FINDINGS: =0.07) use disorders are weak. CONCLUSIONS: In young male and female adults in Australia, the non-medical use of over-the-counter or prescribed analgesics (NMUA) appears to have moderate heritability. NMUA is moderately associated with cannabis and nicotine use and nicotine dependence. Its genetic etiology is largely distinct from that of cannabis and alcohol use disorders.

Authors Gillespie, Nathan A; Bates, Timothy C; Hickie, Ian B; Medland, Sarah E; Verhulst, Brad; Kirkpatrick, Robert M; Kendler, Kenneth S; Martin, Nicholas G; Benotsch, Eric G
Journal Addiction
Pages 2229-2240
Volume 114
Date 1/07/2019
Grant ID R21 DA038852
Funding Body NIDA NIH HHS
URL http://www.ncbi.nlm.nih.gov/pubmed/?term=10.1111/add.14750
Download Article